Related Experiment Videos
Cellular control of gene expression by T-type cyclin/CDK9 complexes.
1Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, 3307 North Broad St., Philadelphia, PA 19140, USA.
Gene
|July 28, 2004
Summary
Cyclin-Dependent Kinase 9 (CDK9), activated by T-type cyclins, forms Positive-Transcription Elongation Factor b (P-TEFb). P-TEFb enhances gene expression by regulating RNA polymerase II transcriptional elongation.
Area of Science:
- Molecular Biology
- Gene Regulation
- Biochemistry
Background:
- Cyclin-Dependent Kinases (CDKs) are crucial regulators of cell cycle and transcription.
- CDK9, a key CDK, plays a vital role in controlling gene expression.
- Understanding CDK9's function is essential for deciphering transcriptional regulation.
Purpose of the Study:
- To review the mechanisms regulating T-type cyclin/CDK9 complexes.
- To discuss how these complexes control gene expression.
- To highlight recent advancements in understanding productive transcriptional elongation.
Main Methods:
- This review synthesizes existing research on CDK9 and its associated proteins.
- It focuses on the biochemical mechanisms of P-TEFb activation and function.
- The review integrates findings on the regulation of RNA polymerase II and elongation factors.
Main Results:
- CDK9, when activated by T-type cyclins and cyclin K, forms P-TEFb.
- P-TEFb phosphorylates the C-terminal domain of RNA polymerase II, promoting transcriptional elongation.
- P-TEFb also acts on negative elongation factors, facilitating productive transcription.
Conclusions:
- CDK9 is a central regulator of transcriptional elongation.
- The activity of T-type cyclin/CDK9 complexes is tightly controlled.
- These complexes are critical for efficient gene expression and cellular function.